European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

MT Newswires Live03-19 23:25

European equities traded in the US as American depositary receipts were down sharply late Thursday morning, as the S&P Europe Select ADR Index dropped 0.5% to 1,711.73.

From continental Europe, the gainers were led by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which climbed 8.5% and 3.2% respectively. They were followed by pharmaceutical company Sanofi (SNY) and software firm SAP (SAP), which advanced 2.4% and 0.7% respectively.

The decliners from continental Europe were led by lender Banco Santander (SAN) and biopharmaceutical company Grifols (GRFS), which dropped 2.8% and 3.1% respectively. They were followed by telecommunications company Nokia (NOK) and biotech firm BioNTech (BNTX), which were down 2% and 1.5% respectively.

The gainers from the UK were led by oil and gas company BP (BP) and biopharmaceutical company Amarin (AMRN), which rose 4.3% and 1.3% respectively. They were followed by biotech company Trinity Biotech (TRIB) and cruise line operator Carnival (CUK), which were up 0.9% and 0.6% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and NuCana (NCNA), which fell 9.8% and 3.5% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and pharmaceutical company Silence Therapeutics (SLN), which were down 14% and 2.7% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment